Literature DB >> 21271306

Serotonergic agents in the management of cluster headache.

Giorgio Lambru1, Manjit Matharu.   

Abstract

Cluster headache is a highly disabling primary headache disorder, characterized by unilateral headache attacks occurring in association with cranial autonomic symptoms. Serotonergic agents, such as the ergot alkaloids, have traditionally been used for the acute and preventive treatment of cluster headache and other primary headaches. Although it initially was thought that their efficacy was due solely to the vasoconstriction of extracranial cerebral vessels, new mechanisms of action of these drugs have been ascertained as a consequence of advances in elucidation of the pathogenesis of primary headaches and the development of triptans. This article reviews the current knowledge about serotonergic agonists and antagonists used in the management of cluster headache, focusing on their mechanisms of action and on the possible role of serotonin system dysfunction in this complex disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21271306     DOI: 10.1007/s11916-011-0176-4

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  68 in total

Review 1.  Methylergonovine maleate as a cluster headache prophylactic: a study and review.

Authors:  L Mueller; R M Gallagher; C A Ciervo
Journal:  Headache       Date:  1997 Jul-Aug       Impact factor: 5.887

2.  Aerosol ergotamine tartrate for migraine and Horton's syndrome.

Authors:  J R GRAHAM; B P MALVEA; H F GRAMM
Journal:  N Engl J Med       Date:  1960-10-20       Impact factor: 91.245

3.  Response of cluster headache to psilocybin and LSD.

Authors:  R Andrew Sewell; John H Halpern; Harrison G Pope
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

Review 4.  Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?

Authors:  José A Terrón
Journal:  Eur J Pharmacol       Date:  2002-03-29       Impact factor: 4.432

5.  5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats.

Authors:  José A Terrón; Esther Martínez-García
Journal:  Eur J Pharmacol       Date:  2007-01-19       Impact factor: 4.432

Review 6.  Side effects of ergotamine.

Authors:  W J Meyler
Journal:  Cephalalgia       Date:  1996-02       Impact factor: 6.292

Review 7.  Evidence base for the medical treatments used in cluster headache.

Authors:  Alok Tyagi; Manjit Matharu
Journal:  Curr Pain Headache Rep       Date:  2009-04

Review 8.  Serotonin and migraine: biology and clinical implications.

Authors:  E Hamel
Journal:  Cephalalgia       Date:  2007-11       Impact factor: 6.292

9.  Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.

Authors:  M H Baf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Int       Date:  1994-01       Impact factor: 3.921

10.  Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.

Authors:  L D CLARK; E L BLISS
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-12
View more
  7 in total

Review 1.  The psychiatric comorbidities of cluster headache.

Authors:  Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2013-02

2.  VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case-Control Study in a Southeastern European Caucasian Population.

Authors:  Maria Papasavva; Michail Vikelis; Vasileios Siokas; Martha-Spyridoula Katsarou; Emmanouil Dermitzakis; Athanasios Raptis; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-14       Impact factor: 3.444

3.  Preliminary Transcriptome Analysis in Lymphoblasts from Cluster Headache and Bipolar Disorder Patients Implicates Dysregulation of Circadian and Serotonergic Genes.

Authors:  Marta Costa; Alessio Squassina; Ignazio Stefano Piras; Claudia Pisanu; Donatella Congiu; Paola Niola; Andrea Angius; Caterina Chillotti; Raffaella Ardau; Giovanni Severino; Erminia Stochino; Arianna Deidda; Antonio M Persico; Martin Alda; Maria Del Zompo
Journal:  J Mol Neurosci       Date:  2015-04-28       Impact factor: 3.444

4.  Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.

Authors:  Martin Andersson; Mari Persson; Anette Kjellgren
Journal:  Harm Reduct J       Date:  2017-09-05

5.  Irritable bowel syndrome and migraine: bystanders or partners?

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

6.  Chronic cluster-like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?

Authors:  Maria M Pineyro; Gabriela Sosa; Maria R Finozzi; Natalia Stecker; Raul Pisabarro; Maria C Belzarena
Journal:  Clin Case Rep       Date:  2017-09-29

7.  A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers.

Authors:  Johannes G Ramaekers; Nadia Hutten; Natasha L Mason; Patrick Dolder; Eef L Theunissen; Friederike Holze; Matthias E Liechti; Amanda Feilding; Kim Pc Kuypers
Journal:  J Psychopharmacol       Date:  2020-08-25       Impact factor: 4.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.